J Korean Neurosurg Soc.  2021 Jan;64(1):100-109. 10.3340/jkns.2020.0071.

Analysis of Mutant Isocitrate Dehydrogenase 1 Immunoexpression, Ki-67 and Programmed Death Ligand 1 in Diffuse Astrocytic Tumours : Study of Single Center in Bandung, Indonesia

Affiliations
  • 1Department of Neurosurgery, Faculty of Medicine, Universitas Padjadjaran-Dr. Hasan Sadikin Hospital, Bandung, Indonesia
  • 2Doctoral Program in Medicine, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
  • 3Department of Biochemistry, Faculty of Medicine, Cenderawasih University, Jayapura, Indonesia
  • 4Oncology and Stem Cell Working Group, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
  • 5Department of Anatomical Pathology, Faculty of Medicine, Universitas Padjadjaran-Dr. Hasan Sadikin Hospital, Bandung, Indonesia

Abstract


Objective
: Diffuse astrocytic tumour (DAT) is a diffuse infiltrative astrocytoma tumour accompanied by molecular parameters such as the presence or absence of isocitrate dehydrogenase (IDH) gene mutations. Ki-67 is a marker for DAT proliferation, while programmed death ligand 1 (PD-L1) indicates an immune evasion mechanism. This study aimed to analyze the correlation among mutant IDH1 R132H, Ki-67, and PD-L1 immunoexpression in the DAT.
Methods
: A cross-sectional study was carried out on 30 paraffin blocks of DAT cases. Paraffin block samples consist of grade II (n=14), grade III (n=8), and grade IV (n=8). In this study, the immunohistochemistry-staining of mutant IDH1 R132H, Ki-67, and PD-L1 were carried out to determine the frequency of DAT with IDH1 mutations.
Results
: Our study shown the frequency of IDH1 mutations in grade II 50.0% (7/14), grade III 37.5% (3/8), and grade IV 12.5% (1/8). Our study also showed a difference in Ki-67 and PD-L1 expression between each the degree of DAT histopathology (p=0.0001 and p=0.002, respectively). There was an association between both mutant IDH1 R132H, and Ki-67 with PD-L1 expression in DAT (p=0.0087 and p=0.0049, respectively).
Conclusion
: DAT with the mutant IDH1 is frequently observed in grade II and small number of grade III. The expression of wild type IDH1, Ki-67, and PD-L1 were found to be higher in high grade DAT (grade III and grade IV). There is a correlation between each of mutant IDH1 status and Ki-67 with PD-L1 expression in DAT.

Keyword

Diffuse astrocytic tumor; Histopathology grade; Mutant IDH1 R132H; Ki-67; PD-L1

Figure

  • Fig. 1. Illustration depicting layers of suprasellar structures associated with pituitary adenoma (asterisk) (sagittal section). Pituitary adenoma grows toward the chiasmatic cistern through the medial opening of the diaphragma sellae (arrowheads), which is extention of dura mater (double arrow), forming the roof of the sellar turcica. Note that the arachnoid membrane (arrow) in the cistern is elevated and attached to the tumor surface due to the upward growth of the pituitary adenoma. Sphe. : sphenoid sinus.

  • Fig. 2. Boxplots and volumetric scatter plots of the variables compared to the degree of arachnoid membrane descent after tumor removal. The categorical variables are depicted with volumetric scatter plots, and continuous variables are presented with boxplots. A : Boxplot of tumor height compared to the degree of arachnoid membrane descent; no correlation (r=0.091, p=0.588). B : Boxplot of the height of the suprasellar extension on pre-operative MR imaging with the degree of arachnoid membrane descent showed a trend towards a correlation, but this was not statistically significant (r=0.285, p=0.083). C : Volumetric scatter plot of tumor composition on pre-operative T2WI compared to the degree of arachnoid membrane descent revealed a strong positive correlation (r=0.571, p<0.01). D : The displacement of the pituitary gland and stalk on pre-operative MR imaging compared to arachnoid membrane descent is presented with the volumetric scatter plot, demonstrating no correlation (r=0.0008, p=0.962). E and F : Boxplots of the area of the medial opening and DS compared to arachnoid membrane descent. Both areas were correlated with the degree of arachnoid membrane descent (area of the medial opening, r=0.340, p=0.037; area of DS, r=0.348, p=0.032), although the ratio of the two areas (G) was not (r=0.241, p=0.145). H : The intra-operative consistency of the tumor depicted with a volumetric scatter plot was not correlated with arachnoid membrane descent (r=-0.299, p=0.073). T2WI : T2-weighted images, DS : diaphragma sellae, MR : magnetic resonance.

  • Fig. 3. Illustrations depicting the degree of arachnoid membrane descent after removal of the tumor with representative cases and corresponding T2WI. A : No descent, although oscillation of the roof structure was verified, it remained at its location without descent. The endoscopic view shows that a whitish membrane-like material covers the DS and is likely to prevent the descent of the upper structure. T2WI of the tumor in this patient exhibits prominent mixed signal intensity. B : Minimal descent, the roof structure descended minimally. There is also a sheet-like whitish patch beneath the upper structure with a vacant space filled by the tumor on the intra-operative photograph. T2WI in this patient showed a cystic component with some mixed signal intensity. C : Moderate, the structure descended as much as the height of the suprasellar extension through the medial opening and its corresponding intra-operative endoscopic view. T2WI shows little mixed signal intensity. D : Marked descent, the structure descended more than the height of extension, and the descended arachnoid membrane is swollen and appears transparent. The intra-operative view shows the arachnoid membrane descended under the pituitary fossa, and homogenous signal intensity is exhibited on T2WI. DS : diaphragma sellae, T2WI : T2-weighted images.


Cited by  1 articles

Current Immunotherapeutic Approaches for Malignant Gliomas
Myung-Hoon Han, Choong Hyun Kim
Brain Tumor Res Treat. 2022;10(1):1-11.    doi: 10.14791/btrt.2022.10.e25.


Reference

References

1. Abdelmaksoud A, Fu P, Alwalid O, Elazab A, Zalloom A, Xiang W, et al. Degrees of diaphragma sellae descent during transsphenoidal pituitary adenoma resection: predictive factors and effect on outcome. Curr Med Sci. 38:888–893. 2018.
Article
2. Campero A, Martins C, Yasuda A, Rhoton AL Jr. Microsurgical anatomy of the diaphragma sellae and its role in directing the pattern of growth of pituitary adenomas. Neurosurgery. 62:717–723. discussion 717-723. 2008.
Article
3. Chi JG, Lee MH. Anatomical observations of the development of the pituitary capsule. J Neurosurg. 52:667–670. 1980.
Article
4. Ciric I. On the origin and nature of the pituitary gland capsule. J Neurosurg. 46:596–600. 1977.
Article
5. Costello RT. Subclinical adenoma of the pituitary gland. Am J Pathol. 12:205–216.1. 1936.
6. Farnoud MR, Kujas M, Derome P, Racadot J, Peillon F, Li JY. Interactions between normal and tumoral tissues at the boundary of human anterior pituitary adenomas. An immunohistochemical study. Virchows Arch. 424:75–82. 1994.
7. Guinto Balanzar G, Abdo M, Mercado M, Guinto P, Nishimura E, Arechiga N. Diaphragma sellae: a surgical reference for transsphenoidal resection of pituitary macroadenomas. World Neurosurg. 75:286–293. 2011.
Article
8. Ju KS, Bae HG, Park HK, Chang JC, Choi SK, Sim KB. Morphometric study of the korean adult pituitary glands and the diaphragma sellae. J Korean Neurosurg Soc. 47:42–47. 2010.
Article
9. Kursat E, Yilmazlar S, Aker S, Aksoy K, Oygucu H. Comparison of lateral and superior walls of the pituitary fossa with clinical emphasis on pituitary adenoma extension: cadaveric-anatomic study. Neurosurg Rev. 31:91–98. discussion 98-99. 2008.
Article
10. Lee EJ, Ahn JY, Noh T, Kim SH, Kim TS, Kim SH. Tumor tissue identification in the pseudocapsule of pituitary adenoma: should the pseudocapsule be removed for total resection of pituitary adenoma? Neurosurgery. 64(3 Suppl):ons62–ons69. discussion ons69-ons70. 2009.
Article
11. Oldfield EH, Vortmeyer AO. Development of a histological pseudocapsule and its use as a surgical capsule in the excision of pituitary tumors. J Neurosurg. 104:7–19. 2006.
Article
12. Peker S, Kurtkaya-Yapicier O, Kiliç T, Pamir MN. Microsurgical anatomy of the lateral walls of the pituitary fossa. Acta Neurochir (Wien). 147:641–648. discussion 649. 2005.
Article
13. Qu X, Xu G, Qu Y, Song T. The pseudocapsule surrounding a pituitary adenoma and its clinical significance. J Neurooncol. 101:171–178. 2011.
Article
14. Tsutsumi S, Ono H, Yasumoto Y, Ishii H. The diaphragma sellae, diaphragm opening, and subdiaphragmatic cistern: an anatomical study using magnetic resonance imaging. Surg Radiol Anat. 41:529–534. 2019.
Article
15. Wei L, Xi Z, Lin S, Zhao Q, Jing J, Wang S. MRI research of diaphragma sellae in patients with pituitary adenoma. Int J Clin Exp Med. 8:12842–12849. 2015.
16. Yasuda A, Campero A, Martins C, Rhoton AL Jr, Ribas GC. The medial wall of the cavernous sinus: microsurgical anatomy. Neurosurgery. 55:179–190. 2004.
Article
17. Yohannan DG, Krishnapillai R, Suresh R, Ramnarayan S. A morphometric study of the foramen of diaphragma sellae and delineation of its relation to optic neural pathways through computer aided superimposition. Anat Res Int. 2015:618042. 2015.
Article
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr